Abstract
A series of novel indazole derivatives have been designed and synthesized by a novel method and evaluated for their antibacterial activity. The compounds were designed to study their interactions as inhibitor of DNA gyrase B. Salicylaldehyde and hydrazine hydrate have been refluxed along with polyethylene glycol and catalytic amount of ptoluenesulfonic acid to yield desired compounds. All the synthesized compounds were subjected to in vitro anti-bacterial activity studies against B. Subtilis, S. aureus, E. coli, P. Aeruiginosa and S. typhi. Substituted compounds I5, I9 and I13 exhibited significant inhibition of bacterial growth. The MIC value of these 3 compounds was found to be 50µg/mL. Compounds substituted at 5th and 6th position of indazole were found to show better hydrogen bond interactions with DNA gyrase B and appreciable potential for anti-bacterial activity. They can be used as potential molecule in bacterial resistance cases. The present studies will be useful for designing selective compounds for inhibition of DNA gyrase B.
Keywords: Hydrazine hydrate, minimum inhibitory concentration, polyethylene glycol, p-toluenesulfonic acid, salicylaldehyde.
Current Bioactive Compounds
Title:Design, Synthesis and Evaluation of Antibacterial Activity of Novel Indazole Derivatives
Volume: 9 Issue: 4
Author(s): Anuruddha Chabukswar, Bhanudas Kuchekar, Pradeep Lokhande, Mangesh Tryambake, Bharat Pagare, Vinayak Kadam, Swati Jagdale and Vasant Chabukswar
Affiliation:
Keywords: Hydrazine hydrate, minimum inhibitory concentration, polyethylene glycol, p-toluenesulfonic acid, salicylaldehyde.
Abstract: A series of novel indazole derivatives have been designed and synthesized by a novel method and evaluated for their antibacterial activity. The compounds were designed to study their interactions as inhibitor of DNA gyrase B. Salicylaldehyde and hydrazine hydrate have been refluxed along with polyethylene glycol and catalytic amount of ptoluenesulfonic acid to yield desired compounds. All the synthesized compounds were subjected to in vitro anti-bacterial activity studies against B. Subtilis, S. aureus, E. coli, P. Aeruiginosa and S. typhi. Substituted compounds I5, I9 and I13 exhibited significant inhibition of bacterial growth. The MIC value of these 3 compounds was found to be 50µg/mL. Compounds substituted at 5th and 6th position of indazole were found to show better hydrogen bond interactions with DNA gyrase B and appreciable potential for anti-bacterial activity. They can be used as potential molecule in bacterial resistance cases. The present studies will be useful for designing selective compounds for inhibition of DNA gyrase B.
Export Options
About this article
Cite this article as:
Chabukswar Anuruddha, Kuchekar Bhanudas, Lokhande Pradeep, Tryambake Mangesh, Pagare Bharat, Kadam Vinayak, Jagdale Swati and Chabukswar Vasant, Design, Synthesis and Evaluation of Antibacterial Activity of Novel Indazole Derivatives, Current Bioactive Compounds 2013; 9 (4) . https://dx.doi.org/10.2174/1573407209999131231095550
DOI https://dx.doi.org/10.2174/1573407209999131231095550 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anti-Chlamydophila pneumoniae Antibodies as Associated Factor for Carotid Atherosclerosis in Patients with AIDS
Current HIV Research Synthesis, In Vitro and In Silico NS5B Polymerase Inhibitory Activity of Benzimidazole Derivatives
Medicinal Chemistry Innate Immunity and Microbes: Conversations with the Gut Leading to Intestinal Tissue Repair and Fibrosis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry COVID-19 and Obesity: Reevaluating the Relationship Through Ca<sup>2+</sup>/cAMP Signalling
Current Drug Research Reviews Balaglitazone: A Second Generation Peroxisome Proliferator-Activated Receptor (PPAR) Gamma (γ) Agonist
Mini-Reviews in Medicinal Chemistry Can Machine Learning and Nanotechnology Help the Fight Against the Current COVID-19 Crisis?
Current Nanoscience Targeting the Histamine H4 Receptor: Future Drugs for Inflammatory Diseases
Current Organic Chemistry Systemic Therapeutic Gene Delivery for Cancer: Crafting Paris Arrow
Current Gene Therapy Structural Determinants of the Multifunctional Profile of Dual Binding Site Acetylcholinesterase Inhibitors as Anti-Alzheimer Agents
Current Pharmaceutical Design Comparative Proteome Profiles of Methicillin-Resistant <i>Staphylococcus aureus</i> in Response to Vanillic Acid and 2-Hydroxycinnamic Acid
Current Proteomics Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of Prostate Cancer Cells: Revealing Signaling Networks
Current Cancer Drug Targets Implications of COVID-19 to Stroke Medicine: An Epidemiological and Pathophysiological Perspective
Current Vascular Pharmacology Synthesis and Antimalarial Activity of Novel Side Chain Modified Antimalarial Agents Derived from 4-Aminoquinoline
Medicinal Chemistry Does the Immune System Regulate Mood to Defend against Infection? Evidence from Studies of Immune Factors, Depression, and Antidepressants
Current Psychiatry Reviews In Silico Study of Structural and Geometrical Requirements of Natural Sesquiterpene Lactones with Trypanocidal Activity
Mini-Reviews in Medicinal Chemistry DFT and <i>In-silico</i> Investigations, along with <i>In-vitro</i> Antitumor and Antimicrobial Assessments of Pharmacological Molecules
Current Organic Synthesis Treating Asthma as a Neuroelectrical Disorder
Inflammation & Allergy - Drug Targets (Discontinued) The NR2B Subtype of NMDA Receptor: A Potential Target for the Treatment of Alcohol Dependence
Current Drug Targets - CNS & Neurological Disorders The Prolyl-Aminodipeptidases and their Inhibitors as Therapeutic Targets for Fibrogenic Disorders
Mini-Reviews in Medicinal Chemistry Pharmacogenetics of Drug Transporters and Its Impact on the Pharmacotherapy
Current Topics in Medicinal Chemistry